Konrad Dabrowski - Innovative Eyewear CoChief Officer
LUCY Stock | USD 6.86 0.30 4.57% |
Executive
Konrad Dabrowski is CoChief Officer of Innovative Eyewear
Age | 41 |
Address | 11900 Biscayne Boulevard, North Miami, FL, United States, 33181 |
Phone | 954 826 0329 |
Web | https://www.lucyd.co |
Innovative Eyewear Management Efficiency
The company has return on total asset (ROA) of (0.5258) % which means that it has lost $0.5258 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.8651) %, meaning that it created substantial loss on money invested by shareholders. Innovative Eyewear's management efficiency ratios could be used to measure how well Innovative Eyewear manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.2 in 2024. Return On Capital Employed is likely to drop to -1.3 in 2024. At this time, Innovative Eyewear's Total Assets are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 57.7 K in 2024, whereas Non Currrent Assets Other are likely to drop slightly above 67.4 K in 2024.Similar Executives
Found 13 records | EXECUTIVE Age | ||
Yew CPA | EUDA Health Holdings | 56 | |
Esq JD | Nutex Health | 60 | |
Michael MD | Nutex Health | 53 | |
Timothy Cruickshank | Heartbeam | 43 | |
Richa Gujarati | Heartbeam | N/A | |
Anand Kumar | Healthcare Triangle | 50 | |
MBA FACHE | Nutex Health | N/A | |
Abhay Borwankar | Healthcare Triangle | N/A | |
Kenneth Persen | Heartbeam | N/A | |
Eugene Johnston | Mangoceuticals, Common Stock | 60 | |
Amanda Hammer | Mangoceuticals, Common Stock | 38 | |
Michael Campana | Healthcare Triangle | N/A | |
Damian David | Healthcare Triangle | N/A |
Management Performance
Return On Equity | -0.87 | ||||
Return On Asset | -0.53 |
Innovative Eyewear Leadership Team
Elected by the shareholders, the Innovative Eyewear's board of directors comprises two types of representatives: Innovative Eyewear inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innovative. The board's role is to monitor Innovative Eyewear's management team and ensure that shareholders' interests are well served. Innovative Eyewear's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innovative Eyewear's outside directors are responsible for providing unbiased perspectives on the board's policies.
Konrad Dabrowski, CoChief Officer | ||
David Cohen, CoFounder CTO | ||
Oswald Gayle, CoChief Officer | ||
Jaoquin Abondano, Chief Officer | ||
Ekene Ofodile, Senior Marketing | ||
Harrison Gross, CEO CoFounder |
Innovative Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innovative Eyewear a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.87 | ||||
Return On Asset | -0.53 | ||||
Operating Margin | (6.95) % | ||||
Current Valuation | 12.49 M | ||||
Shares Outstanding | 2.44 M | ||||
Shares Owned By Insiders | 53.71 % | ||||
Shares Owned By Institutions | 3.51 % | ||||
Number Of Shares Shorted | 185.71 K | ||||
Price To Book | 1.47 X | ||||
Price To Sales | 10.26 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Innovative Stock Analysis
When running Innovative Eyewear's price analysis, check to measure Innovative Eyewear's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innovative Eyewear is operating at the current time. Most of Innovative Eyewear's value examination focuses on studying past and present price action to predict the probability of Innovative Eyewear's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innovative Eyewear's price. Additionally, you may evaluate how the addition of Innovative Eyewear to your portfolios can decrease your overall portfolio volatility.